Objective: To evaluate the association between total cholesterol, low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), total cholesterol to HDL-C ratio, and non-HDL-C with the risk of ischemic stroke in a large cohort of apparently healthy women. Methods: Prospective cohort study among 27,937 US women aged Ն45 years participating in the Women's Health Study who provided baseline blood samples. Stroke occurrence was self-reported and confirmed by medical record review. We categorized plasma lipid measurements into quintiles. We used Cox proportional hazards models to evaluate the association between lipids and risk of ischemic stroke. Results: During 11 years of follow-up, 282 ischemic strokes occurred. All lipid levels were strongly associated with increased risk of ischemic stroke in age-adjusted models. The association attenuated particularly for HDL-C after adjustment for potential confounders. For the comparison of the highest to the lowest quintile, the multivariable-adjusted hazard ratios (95% CI; p for trend across mean quintile values) of ischemic stroke were 2.27 (1.43, 3.60; p trend Ͻ 0.001) for total cholesterol; 1.74 (1.14, 2.66; p trend ϭ 0.003) for LDL-C; 0.78 (0.52, 1.17; p trend ϭ 0.27) for HDL-C; 1.65 (1.06, 2.58; p trend ϭ 0.02) for the total cholesterol to and 2.45 (1.54, 3.91; p trend Ͻ 0.001) for non-HDL-C. Conclusions: In this large cohort of apparently healthy women, total cholesterol, low-density lipoprotein cholesterol, the total cholesterol to high-density lipoprotein cholesterol ratio, and non-high-density lipoprotein cholesterol were significantly associated with increased risk of ischemic stroke.
Results from large trials of cholesterol-lowering statins have shown that these agents decrease the incidence of ischemic stroke among patients with existing strokes or TIAs 1 or at high risk for strokes. [2] [3] [4] However, in contrast to the well-established association between various lipid measures and coronary heart disease, [5] [6] [7] the epidemiologic evidence associating lipid levels with increased risk of ischemic stroke is less clear. Some studies found increased risk of ischemic stroke associated with increased total cholesterol levels [8] [9] [10] [11] [12] [13] [14] [15] while others found no clear association. [16] [17] [18] [19] [20] [21] With regard to cholesterol components, an association between low high-density lipoprotein cholesterol (HDL-C) levels and ischemic stroke has been shown in several studies 11, 12, 14, [22] [23] [24] [25] but the association between low-density lipoprotein cholesterol (LDL-C) and ischemic stroke is less studied and inconsistent. 12, 21 In addition, most of the studies that evaluated the association between lipid levels and ischemic stroke included patients with pre-existing coronary heart disease, 8, 11, 12, 14, 17, 19 or were performed exclusively in men. 8, 9, 11, 16, 20, 23, 24 In women, a large pooled analysis of eight cohort studies found an association between increasing total cholesterol and risk of non-hemorrhagic stroke only for women Ͻ55 years of age but not for older ages. 26 We thus aimed to evaluate the association between lipid levels and risk of subsequent ischemic stroke in the Women's Health Study (WHS), a prospective cohort of Ͼ27,000 apparently healthy women aged 45 years and above with measured lipid profiles at baseline and follow-up information during a mean of 11 years.
Methods. Participants. Study subjects were all participants in the WHS, a completed randomized clinical trial of low-dose aspirin and vitamin E in the primary prevention of cardiovascular disease and cancer among apparently healthy women. The design, methods, and results of the WHS have been described in detail previously. 27, 28 Briefly, a total of 39,876 women who were all registered health professionals throughout the United States and the Commonwealth of Puerto Rico, aged 45 years or older at study entry (1992) (1993) (1994) (1995) , and without a history of cardiovascular disease, cancer, or other major illnesses, were randomly assigned to one of four treatment groups: active aspirin (100 mg on alternate days), active vitamin E (600 IU on alternate days), both active agents, or both placebos. All participants gave written informed consent and the Institutional Review Board of the Brigham and Women's Hospital approved the study design and procedures. Baseline information was self-reported and was collected by a mailed questionnaire that asked about a large number of cardiovascular risk factors and lifestyle variables. Twice in the first year and yearly thereafter, participants were sent follow-up questionnaires asking about study outcomes (including stroke), personal characteristics, medical history, and health habits during the study period. For this analysis, we included follow-up information from the time of randomization through March 31, 2005. Prior to randomization, women were asked whether they would be willing to provide a fasting venous blood sample. Women who answered affirmatively were mailed a blood collection kit containing EDTA tubes. Blood samples were received from 28,345, of which 27,937 of these samples could be assayed for a full lipid panel. Levels of total cholesterol and HDL-C were measured enzymatically on a Hitachi 911 autoanalyzer (Roche Diagnostics, Basel, Switzerland) while LDL-C was determined directly (Genzyme, Cambridge, MA). Non-HDL-C was calculated by subtracting HDL-C from total cholesterol. We categorized all lipid values into quintiles. We further evaluated the association between total cholesterol, LDL-C, and HDL-C based on the Expert Panel on Detection, Evaluation, and Treatment of High Cholesterol in Adults (ATP III) 29 categories and as continuous terms (in mmol/L).
Ascertainment of stroke. Participants who reported a stroke on a follow-up questionnaire were asked for permission to review their medical records. A diagnosis of stroke was confirmed only after review of the medical records by an Endpoints Committee of physicians, including a Board certified vascular neurologist. A nonfatal stroke was defined as a new focal-neurologic deficit of sudden onset and vascular mechanism that lasted Ͼ24 hours. Cases of fatal stroke were documented by evidence of a cerebrovascular mechanism obtained from all available sources, including death certificates, autopsy reports, hospital records, family members, or next of kin. Clinical information and results from diagnostic tests including brain imaging were used to distinguish among ischemic, hemorrhagic, and unknown stroke subtype. Furthermore, ischemic strokes were subcategorized into potential etiologic causes. The interobserver agreement of the classification of stroke and its major subtypes in the WHS was excellent. 30 Statistical analyses. We compared baseline characteristics of participants according to total cholesterol categories. To compare mean response among total cholesterol quintiles, we used analyses of covariance (ANCOVA) adjusting for age. We compared categorical variables adjusting for age using direct standardization. We used Cox proportional hazards models to evaluate the association between the various lipid measures and the risk of ischemic stroke. We calculated age-and multiple-adjusted hazard ratios (HRs) and their corresponding 95% CIs. We made a distinction between two multivariable models: Model 1 controlled for the potential confounding factors age (quadratic term), alcohol consumption (rarely/never, 1 to 3 drinks/month, 1 to 6 drinks/week, Ն1 drinks/day), exercise (rarely/never, Ͻ1 times/week, 1 to 3 times/ week, Ն4 times/week), smoking (never, past, current Ͻ15 cigarettes, current Ն15 cigarettes), body mass index (quartiles), family history of myocardial infarction prior to age 60, current postmenopausal hormone use, history of diabetes, migraine and migraine aura status, and, in addition, for cholesterol lowering medication use and randomized treatment assignments. Because lipid levels have been associated with risk of incident hypertension, 31 and thus, hypertension may be a potential biologic mediator of the lipid-ischemic stroke association, we additionally controlled for systolic blood pressure categories (10 mm Hg increments) as well as for antihypertensive medication use in a second multivariable model.
We evaluated whether the association between total cholesterol and stroke was modified by age (Ͻ55, 55 to 64, Ն65 years), history of hypertension (yes, no), body mass index (Ͻ25, 25 to 29.9, Ն30 kg/m 2 ), smoking status (never, past, current), current postmenopausal hormone use (yes, no), or randomized aspirin assignment that has been shown to reduce the risk of ischemic stroke in the WHS. 27 We performed all analyses by using SAS statistical software (SAS Institute Inc., version 9.1, Cary, NC) and we calculated p for trend across mean values of the lipid quintile categories (p trend ).
All tests are two-tailed and we considered a p Ͻ 0.05 as significant.
Results. The mean age (SD) of the 27,937 participating women was 54.7 (7.1) years, 94.5% were white, 1.8% black, and 3.7% of other ethnicity. All participants were health care professionals of whom 12.3% had education in licensed practical or vocational nursing, 11.0% had a completed 2-year and 31.6% a 3-year associate registered nursing training, 23.2% had bachelor degrees, 14.8% master degrees, and 5.4% had doctoral degrees.
In table 1, we summarize the association between total cholesterol quintiles and various baseline characteristics. Compared to women in the lowest total cholesterol quintile (Ͻ179 mg/dL [Ͻ4.60 mmol/L]), women in the highest quintile (Ն244 mg/dL [Ն6.31 mmol/L]) had a higher body mass index and higher systolic blood pressure values; were more likely to report a history of hypertension, diabetes, or migraine; were more likely to be a current smoker, to exercise less, and to report a family history of premature myocardial infarction; were less likely to currently use postmenopausal hormones; and were more likely to use cholesterol lowering medication.
During a mean of 11 years of follow-up (307,769 personyears), a total of 282 ischemic strokes were confirmed, which translates to an incidence rate of ischemic stroke of 9.2 (95% CI, 8.2 to 10.3) per 10,000 women per year. In age-adjusted analyses, we found strong associations between all lipid level quintiles and risk of subsequent ischemic stroke (table 2). After additional adjustment for potential confounders and randomized treatment assignments, the effect estimates were attenuated. Compared to women in the lowest quintile, those in the highest quintile had (model 1)-adjusted HRs (95% CIs; p for trend across mean values of quintile categories) of ischemic stroke of 2.27 (1.43 to 3.60; p trend Ͻ 0.001) for total cholesterol; 1.74 (1.14 to 2.66, p trend ϭ 0.003) for LDL-C; 0.78 (0.52 to 1.17, p trend ϭ 0.27) for HDL-C; 1.65 (1.06 to 2.58, p trend ϭ 0.02) for total cholesterol to HDL-C ratio; and 2.45 (1.54 to 3.91, p trend Ͻ 0.001) for non-HDL-C. Further control for markers of the potential biologic mediator hypertension slightly attenuated these risk estimates (table 2) , still leaving significant trends across mean total cholesterol, LDL-C, and non-HDL-C quintiles. We tested for significant deviation from linearity across mean values of cholesterol quintiles and found no violation.
When we categorized lipid values based on the ATP III recommendations, 29 the model 1-adjusted HRs (95% CIs, p for trend across mean values of categories) of ischemic stroke were 1.70 (1.24 to 2.33; p trend ϭ 0.001) for total cholesterol Ն240 mg/dL (Ͼ6.21 mmol/L) (when compared to total cholesterol Ͻ200 mg/dL [Ͻ5.17 mmol/L]); 1.59 (1.06 to 2.39, p trend ϭ 0.003) for LDL-C Ն160 mg/dL (Ն4.14 mmol/L) (when compared to LDL-C Ͻ100 mg/dL [Ͻ2.59 mmol/L]); and 0.78 (0.54 to 1.13, p trend ϭ 0.23) for HDL-C Ն60 mg/dL (Ն1.55 mmol/L) (when compared to HDL-C Ͻ40 mg/dL [Ͻ1.03 mmol/L]). As with quintile categories, additional control for systolic blood pressure and antihypertensive medication use attenuated these estimates, still leaving significant trends across mean ATP III categories for total cholesterol and LDL-C.
When we evaluated lipid levels as continuous measure, a one millimole per liter-unit increase of cholesterol measures (38.7 mg/dL) was associated with a model 1-adjusted HR for ischemic stroke of 1.17 (95% CI, 1.06 to 1.30; p ϭ 0.003) for total cholesterol, 1.15 (95% CI, 1.01 to 1.31; p ϭ 0.029) for LDL-C, 0.91 (95% CI, 0.64 to 1.28; p ϭ 0.58) for HDL-C, and 1.19 (95% CI, 1.07 to 1.32; p ϭ 0.001) for non-HDL-C. While there was a significant linear trend for all continuous cholesterol measures, the association between continuous total cholesterol and ischemic stroke appeared to be curve-linear (p value for quadratic term ϭ 0.03), indicating exponentially increasing risk particularly for high total cholesterol values.
We furthermore evaluated which lipid measure is the best statistical predictor of ischemic stroke risk by con-trasting a multivariable model (model 1) to a model that additionally included indicator variables for the various lipid measure quintiles, using a four-degree of freedom likelihood ratio test. The strongest predictive model for ischemic stroke was the model that included non-HDL-C ( 2 ϭ 24.3, p Ͻ 0.001) followed by the model that included total cholesterol ( 2 ϭ 15.7, p ϭ 0.004), and the model that included LDL-C ( 2 ϭ 14.6, p ϭ 0.006). All other lipid measures did not significantly improve the prediction of stroke when added to the multivariable model that also included non-HDL-C. The association between total cholesterol ATP III categories and ischemic stroke was not modified by age (p interaction ϭ 0.43), smoking status (p interaction ϭ 0.32), body mass index (p interaction ϭ 0.15), history of hyperten-sion (p interaction ϭ 0.59), or randomized aspirin assignment (p interaction ϭ 0.21). We found effect modification by current postmenopausal hormone use (p interaction ϭ 0.02), suggesting that women who used postmenopausal hormones did A large study of over 11,000 patients with coronary heart disease showed a 14% increase in the relative risk of verified ischemic stroke or TIA per 40 mg/dL (1.03 mmol/L) increase in LDL-C. 12 In contrast, a large cohort study of over 14,000 middle-aged men and women found no consistent association between LDL-C and ischemic stroke during 10 years of follow-up. 21 With regard to HDL-C, several studies found a significant association between HDL-C and ischemic stroke after adjustment for potential confounders. 11, 12, 14, 24, 25 In a large prospective cohort of 7,735 men, men in the top fifth percentile of HDL-C (Ն1.33 mmol/L) had a significant 40% reduction in risk of nonfatal stroke when compared to the lowest fifth percentile. 24 A multiethnic case-control study of elderly individuals showed significant associations between HDL-C and risk of ischemic stroke after confounder adjustment. 25 Compared to participants with HDL-C values of Ͻ35 mg/dL (Ͻ91 mmol/L), participants with Ն50 mg/dL (Ն1.29 mmol/L) had odds ratio of 0.31 (95% CI, 0.21 to 0.46). The association was not modified by gender or ethnicity. Overall, the published data strongly suggest that lower HDL-C levels are associated with increased risk of ischemic stroke.
Some studies have suggested that the association between lipid levels and ischemic stroke differs within the ischemic stroke subtypes. 9, 14, 25 In a health insurance-based case-control study, total cholesterol was more strongly associated with ischemic strokes of the atherosclerotic and lacunar subtypes. 14 Furthermore, in that study 14 and the previously mentioned case-control study, 25 high HDL-C levels were more strongly associated with the atherosclerotic subtype. In the WHS, total cholesterol appeared also to be more strongly associated with the atherosclerotic and lacunar ischemic stroke subtype (data not shown). However, since the number of outcome events in the ischemic stroke subtype categories was small and the interrater agreement for ischemic stroke subtypes was only moderate, 30 our ability to assess this issue is limited.
Several large randomized trials among individuals with existing or at high risk for cardiovascular disease have shown that lipid lowering therapy with statins results in reduced risk of ischemic stroke. [1] [2] [3] [4] The data of the randomized trials, the data of others, and our data strongly support the notion that lipids are a biologic risk factor for ischemic stroke and that avoiding unfavorable cholesterol levels may help to prevent ischemic stroke as recommended the primary prevention guidelines of the American Heart Association/American Stroke Association. 40 Our results further underscore the importance of unfavorable lipid levels as risk factor for first ischemic stroke among apparently healthy individuals without prior vascular disease.
